Brian Abrahams
Stock Analyst at RBC Capital
(2.16)
# 2,893
Out of 5,002 analysts
434
Total ratings
41.7%
Success rate
-5.15%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Downgrades: Sector Perform | $67 → $10 | $6.80 | +47.06% | 3 | Sep 29, 2025 | |
| APGE Apogee Therapeutics | Initiates: Outperform | $60 | $38.95 | +54.06% | 1 | Sep 25, 2025 | |
| INCY Incyte | Maintains: Sector Perform | $72 → $81 | $86.78 | -6.66% | 23 | Sep 24, 2025 | |
| ATYR aTyr Pharma | Downgrades: Sector Perform | $16 → $1.5 | $0.71 | +111.86% | 1 | Sep 16, 2025 | |
| KYMR Kymera Therapeutics | Initiates: Outperform | $70 | $54.72 | +27.92% | 1 | Sep 16, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Outperform | $144 → $149 | $136.64 | +9.05% | 22 | Sep 5, 2025 | |
| SION Sionna Therapeutics | Initiates: Sector Perform | $22 | $27.19 | -19.07% | 1 | Sep 3, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Outperform | $55 | $38.64 | +42.34% | 16 | Sep 2, 2025 | |
| AARD Aardvark Therapeutics | Maintains: Outperform | $20 → $19 | $14.73 | +28.99% | 4 | Aug 14, 2025 | |
| PTCT PTC Therapeutics | Maintains: Outperform | $60 → $63 | $62.00 | +1.61% | 21 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $96 → $98 | $108.86 | -9.98% | 32 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $11 | $14.89 | -26.12% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $40 | $21.15 | +89.13% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $430 → $405 | $408.98 | -0.97% | 55 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $10.08 | -0.79% | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $688 → $695 | $601.94 | +15.46% | 33 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $208 → $219 | $154.19 | +42.04% | 39 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $23 | $22.41 | +2.66% | 35 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $13 | $7.31 | +77.84% | 19 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $35 → $75 | $98.52 | -23.87% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $31 | $10.91 | +184.17% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $1.5 | $0.76 | +97.37% | 6 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $33 | $6.30 | +423.81% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $58 | $13.33 | +335.11% | 8 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $32.85 | +155.75% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $13.36 | +132.04% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.44 | +109.06% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $1.81 | +120.99% | 6 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $119.36 | +19.81% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $29.55 | +35.36% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $32 → $30 | $35.63 | -15.80% | 11 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $11.90 | +84.87% | 9 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $10.36 | +44.79% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $5.10 | +76.64% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $33 | $94.08 | -64.92% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $30.47 | - | 4 | Dec 4, 2017 |
MoonLake Immunotherapeutics
Sep 29, 2025
Downgrades: Sector Perform
Price Target: $67 → $10
Current: $6.80
Upside: +47.06%
Apogee Therapeutics
Sep 25, 2025
Initiates: Outperform
Price Target: $60
Current: $38.95
Upside: +54.06%
Incyte
Sep 24, 2025
Maintains: Sector Perform
Price Target: $72 → $81
Current: $86.78
Upside: -6.66%
aTyr Pharma
Sep 16, 2025
Downgrades: Sector Perform
Price Target: $16 → $1.5
Current: $0.71
Upside: +111.86%
Kymera Therapeutics
Sep 16, 2025
Initiates: Outperform
Price Target: $70
Current: $54.72
Upside: +27.92%
Neurocrine Biosciences
Sep 5, 2025
Maintains: Outperform
Price Target: $144 → $149
Current: $136.64
Upside: +9.05%
Sionna Therapeutics
Sep 3, 2025
Initiates: Sector Perform
Price Target: $22
Current: $27.19
Upside: -19.07%
Xenon Pharmaceuticals
Sep 2, 2025
Reiterates: Outperform
Price Target: $55
Current: $38.64
Upside: +42.34%
Aardvark Therapeutics
Aug 14, 2025
Maintains: Outperform
Price Target: $20 → $19
Current: $14.73
Upside: +28.99%
PTC Therapeutics
Aug 8, 2025
Maintains: Outperform
Price Target: $60 → $63
Current: $62.00
Upside: +1.61%
Aug 8, 2025
Maintains: Sector Perform
Price Target: $96 → $98
Current: $108.86
Upside: -9.98%
Aug 8, 2025
Maintains: Sector Perform
Price Target: $12 → $11
Current: $14.89
Upside: -26.12%
Aug 7, 2025
Maintains: Outperform
Price Target: $39 → $40
Current: $21.15
Upside: +89.13%
Aug 5, 2025
Maintains: Sector Perform
Price Target: $430 → $405
Current: $408.98
Upside: -0.97%
Aug 5, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $10.08
Upside: -0.79%
Aug 4, 2025
Maintains: Sector Perform
Price Target: $688 → $695
Current: $601.94
Upside: +15.46%
Aug 1, 2025
Maintains: Outperform
Price Target: $208 → $219
Current: $154.19
Upside: +42.04%
Jul 17, 2025
Maintains: Sector Perform
Price Target: $25 → $23
Current: $22.41
Upside: +2.66%
Jun 30, 2025
Reiterates: Outperform
Price Target: $13
Current: $7.31
Upside: +77.84%
Jun 24, 2025
Maintains: Outperform
Price Target: $35 → $75
Current: $98.52
Upside: -23.87%
May 15, 2025
Reiterates: Outperform
Price Target: $31
Current: $10.91
Upside: +184.17%
May 14, 2025
Reiterates: Sector Perform
Price Target: $1.5
Current: $0.76
Upside: +97.37%
May 13, 2025
Maintains: Outperform
Price Target: $34 → $33
Current: $6.30
Upside: +423.81%
May 7, 2025
Maintains: Outperform
Price Target: $65 → $58
Current: $13.33
Upside: +335.11%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $32.85
Upside: +155.75%
Mar 7, 2025
Initiates: Outperform
Price Target: $31
Current: $13.36
Upside: +132.04%
Mar 4, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.44
Upside: +109.06%
Mar 4, 2025
Reiterates: Sector Perform
Price Target: $4
Current: $1.81
Upside: +120.99%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $119.36
Upside: +19.81%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $29.55
Upside: +35.36%
Nov 1, 2024
Maintains: Sector Perform
Price Target: $32 → $30
Current: $35.63
Upside: -15.80%
Jun 5, 2024
Reiterates: Outperform
Price Target: $22
Current: $11.90
Upside: +84.87%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $10.36
Upside: +44.79%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $5.10
Upside: +76.64%
Nov 3, 2021
Maintains: Sector Perform
Price Target: $21 → $33
Current: $94.08
Upside: -64.92%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $30.47
Upside: -